Mandrax use, sexual risk, and opportunities for pre-exposure prophylaxis among out-of-school adolescent girls and young women in Cape Town, South Africa

In South Africa (SA), adolescent girls and young women (AGYW) aged 15 - 24 years account for nearly 25% of all new HIV infections in the country. The intersection of substance use and sexual risk continues to drive the HIV epidemic among AGYW. For example, methaqualone, also known as Mandrax, has se...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	SAMJ: South African Medical Journal 2022-05, Vol.112 (5), p.341-346
Hauptverfasser:	Bonner, C P, Browne, F A, Carney, T, Shangase, N, Ndirangu, J W, Myers, B, Wechsberg, W M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Anti-HIV Agents - therapeutic use Complications and side effects Diphenhydramine Drug Combinations Drug use Female Health aspects Health Care Sciences & Services Health Policy & Services HIV Infections - drug therapy HIV Infections - epidemiology HIV Infections - prevention & control Humans Hypnotics Medical Ethics Medicine, General & Internal Medicine, Legal Medicine, Research & Experimental Methaqualone - therapeutic use Pre-Exposure Prophylaxis - methods Prevention Risk factors Risk-taking (Psychology) Sedatives Sexual Behavior Sexually transmitted diseases South Africa - epidemiology Substance-Related Disorders Teenage girls Young women
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!